Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: A phase II study of the radiation therapy oncology group
โ Scribed by Arturo A. Ydrach; Victor A. Marcial; J. Parsons; J. Concannon; S.O. Asbell; F. George
- Publisher
- Elsevier Science
- Year
- 1982
- Tongue
- English
- Weight
- 322 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract The Radiation Therapy Oncology Group (RTOG) initiated a phase I/II study of intraoperative radiotherapy (IORT) in advanced or recurrent rectal cancer to assess therapeutic efficacy, toxicity, and establish quality control guidelines prior to beginning a phase III trial. From October 198
## Background: A multiinstitutional, prospective study of the radiation therapy oncology group (rtog) was designed to determine the feasibility and toxicity of chemotherapy, external beam radiation, and esophageal brachytherapy (eb) in a potentially curable group of patients with adenocarcinoma or
The Radiation Therapy Oncology Group has conducted several randomized clinical trials to evaluate the efficacy of various radiation therapy schedules in palliating symptomatic brain and bone metastases. Among the patients entered in these studies, there were 225 patients with primary tumors of the g